Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOBEC3A | P31941 | 2/20 | 0.48 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.48 |
| ▸ | CHRNA7 | P36544 | 7/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.43 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.43 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.43 |
| ▸ | CCR5 | P51681 | 2/20 | 0.43 |
| ▸ | ACHE | P22303 | 4/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | RAD52 | P43351 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL4082000 | 0.98 | APOBEC3A (0.47) | APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7 | |
| Bromide SCHEMBL10751445 | 0.98 | APOBEC3A (0.47) | APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7 | |
| Hydrochloric Acid SCHEMBL10751415 | 0.98 | APOBEC3A (0.47) | APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7 | |
| SCHEMBL10257015 | 0.98 | APOBEC3A (0.47) | APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7 | |
| SCHEMBL12682901 | 0.82 | CHRNA7 (0.44) | APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7 | |
| SCHEMBL3681307 | 0.81 | CHRNA7 (0.60) | APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7 | |
| SCHEMBL20017727 | 0.81 | CHRNA7 (0.43) | APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7 | |
| SCHEMBL6773387 | 0.81 | CHRNA7 (0.43) | APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7 | |
| SCHEMBL10256901 | 0.79 | CHRNB2 (0.61) | APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7 | |
| SCHEMBL724930 | 0.79 | CHRNB2 (0.61) | APOBEC3AAPOBEC3GCYP2D6CTDSP1CHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107117641-A | Using N methyl N Benzvlmorpholin ionic liquid synthetizing micro-nanos Cu2O method | 龙岩学院 | 2017-09-01 | — | — | CN | claimed |
| EP-0684248-B1 | Process for the preparation of tertiary diarylalkylphosphines | CELANESE CHEM EUROPE GMBH (DE) | 2001-08-29 | — | — | EP | claimed |
| US-5527967-A | Process for preparing tertiary diarylalkylphosphines | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-06-18 | — | — | US | claimed |
| EP-0684248-A1 | Process for the preparation of tertiary diarylalkylphosphines | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-11-29 | — | — | EP | claimed |
| US-20240025839-A1 | METHOD OF SYNTHESIS | UNIVERSITY OF DURHAM (GB) | 2024-01-25 | — | — | US | disclosed |
| US-11807610-B2 | Functionalized ionic liquid for solvating heavy aromatic compounds | CHEVRON U.S.A. INC. (US) | 2023-11-07 | — | — | US | disclosed |
| WO-2023152607-A1 | FUNCTIONALIZED IONIC LIQUID FOR SOLVATING HEAVY AROMATIC COMPOUNDS | CHEVRON U.S.A. INC. (US) | 2023-08-17 | — | — | WO | disclosed |
| US-20230250061-A1 | FUNCTIONALIZED IONIC LIQUID FOR SOLVATING HEAVY AROMATIC COMPOUNDS | CHEVRON U.S.A. INC. | 2023-08-10 | — | — | US | disclosed |
| EP-2513028-B1 | METHOD FOR PREPARING ALIZARIN DERIVATIVE COMPOUND, NOVEL ALIZARIN DERIVATIVE COMPOUND, USE OF SAID ALIZARIN COMPOUND, PHOTOELECTRIC CONVERSION FILM, PHOTOELECTRIC CONVERSION ELEMENT, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR | FUJIFILM CORP (JP) | 2018-06-20 | — | — | EP | disclosed |
| CN-107117641-A | Using N methyl N Benzvlmorpholin ionic liquid synthetizing micro-nanos Cu2O method | 龙岩学院 | 2017-09-01 | — | — | CN | disclosed |
| US-8993216-B2 | Method of producing a planographic printing plate | FUJIFILM CORPORATION (JP) | 2015-03-31 | — | — | US | disclosed |
| US-8741513-B2 | Method for preparing alizarin derivative compound, novel alizarin derivative compound, surface modification method, photoelectric conversion film, photoelectric conversion element, and electrophotographic photoreceptor | FUJIFILM CORPORATION (JP) | 2014-06-03 | — | — | US | disclosed |
| US-7312208-B2 | Quaternary ammonium compounds | ASAHI KASEI PHARMA CORPORATION (JP) | 2007-12-25 | — | — | US | disclosed |
| US-20070203115-A1 | Novel quaternary ammonium compounds | ASAHI KASEI PHARMA CORPORATION (JP) | 2007-08-30 | — | — | US | disclosed |
| US-20070190041-A1 | Novel benzothiazepine and bensothiepine compounds | ASHAI KASEI PHARAMA CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-7186500-B2 | Silver halide photographic lightsensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 2007-03-06 | — | — | US | disclosed |
| US-7186500-B2 | Silver halide photographic lightsensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 2007-03-06 | — | — | US | disclosed |
| EP-0684248-B1 | Process for the preparation of tertiary diarylalkylphosphines | CELANESE CHEM EUROPE GMBH (DE) | 2001-08-29 | — | — | EP | disclosed |
| US-5527967-A | Process for preparing tertiary diarylalkylphosphines | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-06-18 | — | — | US | disclosed |
| EP-0684248-A1 | Process for the preparation of tertiary diarylalkylphosphines | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-11-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240025839-A1 | METHOD OF SYNTHESIS | NIT2, NAA15, ASNS | APOBEC3A 1990/4885APOBEC3G 1763/4885CYP2D6 933/4885 |
| US-11807610-B2 | Functionalized ionic liquid for solvating heavy aromatic compounds | AHR, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PAH | APOBEC3A 738/4885APOBEC3G 379/4885CYP2D6 1314/4885 |
| US-20070203115-A1 | Novel quaternary ammonium compounds | SLC10A2, SLC10A1, ABCB11 | APOBEC3A 4529/4885APOBEC3G 4525/4885CYP2D6 820/4885 |
| US-20230250061-A1 | FUNCTIONALIZED IONIC LIQUID FOR SOLVATING HEAVY AROMATIC COMPOUNDS | AHR, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PAH | APOBEC3A 738/4885APOBEC3G 379/4885CYP2D6 1314/4885 |
| US-20070190041-A1 | Novel benzothiazepine and bensothiepine compounds | SLC10A1, GOT1, CES1 | APOBEC3A 4755/4885APOBEC3G 4848/4885CYP2D6 1881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.